• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/35

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

35 Cards in this Set

  • Front
  • Back
Kleine-Levin
- "sleeping beauty"
- Hypersomnolence
- Hyperphagia
- Hypersexuality
- Mood and behavior changes
Kluver-Bucy
- Bilateral medial temporal lobes (amygdala)
- Docility
- Hyperorality
- Hyperphagia
- Hypersexuality
- Visual agnosia
Thallium toxicity
- Axonal peripheral neuropathy, ascending
- Alopecia
- Pain and paresthesias starting with soles of feet
- Distal>proximal weakness
- MRI normal
Serotonin syndrome
- Site of disorder: CNS
- Caused by SSRIs with or without MAOi, TCA, meperidine
- Tachycardia/HTN, diaphoresis/shivering, nausea/diarrhea, myoclonus, hyperreflexia, hyperthermia, seizures, coma
- Treatment is supportive
Bechet's disease
- Mucocutaneous, ocular, cardiovascular, renal, GI, pulmonary, and CNS
- Presence of oral aphthous ulcers and 2 other ulcers or vasculitidities
Sturge-Weber disease
- Neurocutaneous disorder involving leptomeninges, skin of face in V1 and V2
- Port-wine stain
- Ocular manifestations include ocular choroidal angiomas and glaucoma
Organophosphate poisoning
- Cholinergic syndrome
- Pinpoint pupils
- SLUDGE: salivation, lacrimation, urination, diaphoresis, GI motility, emesis
- Otherwise known as "fluid coming out of everywhere"
Lead
- Peripheral neuropathy
Giant cell arteritis
- Systemic symptoms are protective against CNS involvement
- Visual loss occurs in 8%
- Stroke occurs in 7%
Toxins: Botulism
- Presynaptic membrane (SNARE protein cleavage, no Ach release)
- Nausea, vomiting, diarrhea -> constipation, generalized weakness.
- Foodborne develops over 12-36 hours
- Wound borne develops over days to weeks.
Toxins: Tick paralysis
- Block NMJ transmission, or block Na channels at Nodes of Ranvier
- Rapidly ascending weakness
- Remove tick
Toxins: Tetrodotoxin
- Presynaptic Na+ channel blocker
- Found in pufferfish
Toxins: Saxitoxin
- Presynaptic Na+ channel blocker
- Dinoflagellates (red tide), shellfish that feed on them
Toxins: Ciguatoxin
- Presynsaptic Na+ channel blocker
- Dinoflagellates, reef fish
- Abdominal pain, oral and acral paresthesias, altered temperature sensation
Toxins: Aminopyradines (dalfampridine)
- Presynaptic K+ channel blocker
- Slows repolarization and promotes Ach release
- Used in treatment of Lambert Eaton syndrome
Toxins: Dendrotoxin
- Presynaptic K+ channel blocker
- Black or green mamba snake
Toxins: Notexin
- Presynaptic K+ channel blocker
- Australian tiger snake
Medications which worsen myasthenia
- Ca2+ blockers
- Antibiotics (aminoglycosides)
- Mg2+
Toxins: Conotoxins
- Presynaptic Ca2+ channel blocker
- Found in marine snails
Toxins: Organophosphates
- Include weaponized nerve agents such as soman, sarin, VX
- Insecticides
- Hypercholinergic state
- Treat with atropine
Toxins: Curare
- Postsynaptic AchR blocker
- Vec, pancuronium have similar mech of action
Toxins: alpha bungarotoxin
- Postsynaptic AchR blocker
- Banded krait (cobratoxin by siamese cobra)
Manganese toxicity
- Bilateral basal ganglia and midbrain lesions on MRI
Neuroleptic malignant syndrome
- Site of disorder: CNS
- Antipsychotics, especially depot
- Rigidity, encephalopathy, autonomic instability, dystonia, tremor, chorea, hyperthermia
- Treat with dantrolene, dopaminergic agents, withdraw medication
Malignant hyperthermia
- Site of disorder: muscle
- Halogenated anesthetics or depolarizing anesthetics in patients with ryanodine receptor mutation
- Jaw clenching, respiratory acidosis, cyanosis, myoglobinuria
- Withdraw medication, dantrolene, bicarbonate
Acute lethal catatonia
- Site of disorder: CNS
- Exacerbated psychotic disorder
- Psychosis, dyskinesia, waxy flexibility (not true rigidity)
- treat with ECT
Neuroleptic malignant syndrome
- Site of disorder: CNS
- Antipsychotics, especially depot
- Rigidity, encephalopathy, autonomic instability, dystonia, tremor, chorea, hyperthermia
- Treat with dantrolene, dopaminergic agents, withdraw medication
Malignant hyperthermia
- Site of disorder: muscle
- Halogenated anesthetics or depolarizing anesthetics in patients with ryanodine receptor mutation
- Jaw clenching, respiratory acidosis, cyanosis, myoglobinuria
- Withdraw medication, dantrolene, bicarbonate
Acute lethal catatonia
- Site of disorder: CNS
- Exacerbated psychotic disorder
- Psychosis, dyskinesia, waxy flexibility (not true rigidity)
- treat with ECT
Causes of head drop
myasthenia
ploymyositis
ALS
Causes of head drop
myasthenia
ploymyositis
ALS
Causes of head drop
myasthenia
ploymyositis
ALS
Spastic paraplegia
Focal spinal cord disease
SCD
tethered cord
DOPA responsive dystonia
Leukodystrophies
SCA-3
Friedreich's ataxia
Episodic ataxia I
- voltage gated K+ channel
- Onset 20-30 years
- Ataxia only lasting 1-2 minutes, emotion or change in position
- without nystagmus
- Treat with antiepileptics, avoid acetozolamide
Episodic ataxia II
- mutations of p/q type voltage gated ca2+ channel (CACNA1A)
- lasts more than 10 minutes to hours
- triggered by exercise or stress
- with nystagmus
- Treat with acetazolamide